Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Salbutamol sulfate 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
|
Albuterol sulfate 2mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
|
Salbutamol (as salbutamol sulfate) 210 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
|
Salbutamol sulfate 417 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
|
Albuterol sulfate 2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
|
Albuterol sulfate 100mcg/dose |
Is a |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
|
Albuterol sulfate + ipratropium bromide 103mcg/18mcg aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
|
Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
|
Albuterol sulfate + ipratropium bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
|
Salbutamol (as salbutamol sulfate) 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
|
Salbutamol 2mg/5mL sugar free syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
|
Salbutamol (as salbutamol sulfate) 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol sulfate 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol sulfate 8 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 8 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 4 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol sulfate 8 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 400 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 95 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 100 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Albuterol (as albuterol sulfate) 100 microgram/actuation pressurized suspension for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 500 microgram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/50 milliliter conventional release solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/5 milliliter conventional release solution for infusion ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 500 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol sulfate 417 microgram/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol sulfate 417 microgram/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 830 microgram/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 210 microgram/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 2.5 mg/actuation solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Ipratropium bromide 200 microgram/mL and salbutamol (as salbutamol sulfate) 1 mg/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Choline theophyllinate 20 mg/mL and salbutamol (as salbutamol sulfate) 400 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 100 microgram/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 1 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 200 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for nebulizer (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Salbutamol sulfate |
Inferred relationship |
Some |
1 |